Linlin Wang

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 25

Top Topics

Locally Advanced

Systematic Review

Tyrosine Kinase

Top Venues

Journal of translational medicine

Cancer medicine

Cancer management and research

Clinical and translational medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Butuo Li, Wenru Qin, Linlin Yang, Haoqian Li, Chao Jiang, Yueyuan Yao, Shuping Cheng, Bing Zou, Bingjie Fan, Taotao Dong, Linlin Wang
From pixels to patient care: deep learning-enabled pathomics signature offers precise outcome predictions for immunotherapy in esophageal squamous cell cancer. Journal of translational medicine 22 (1) (2024)
Butuo Li, Wenru Qin, Linlin Yang, Haoqian Li, Chao Jiang, Yueyuan Yao, Shuping Cheng, Bing Zou, Bingjie Fan, Taotao Dong, Linlin Wang
From pixels to patient care: deep learning-enabled pathomics signature offers precise outcome predictions for immunotherapy in esophageal squamous cell cancer. Journal of translational medicine 22 (1) (2024)
Yiyue Xu, Haoqian Li, Xiaoqing Wang, Butuo Li, Aiqin Gao, Qian Zhao, Linlin Yang, Wenru Qin, Linlin Wang
Development and Validation of Nomograms for Predicting Pneumonia in Patients with COVID-19 and Lung Cancer. Journal of inflammation research 17 (2024)
Butuo Li, Wenru Qin, Linlin Yang, Haoqian Li, Chao Jiang, Yueyuan Yao, Shuping Cheng, Bing Zou, Bingjie Fan, Taotao Dong, Linlin Wang
From pixels to patient care: deep learning-enabled pathomics signature offers precise outcome predictions for immunotherapy in esophageal squamous cell cancer. Journal of translational medicine 22 (1) (2024)
Butuo Li, Wenru Qin, Linlin Yang, Haoqian Li, Chao Jiang, Yueyuan Yao, Shuping Cheng, Bing Zou, Bingjie Fan, Taotao Dong, Linlin Wang
From pixels to patient care: deep learning-enabled pathomics signature offers precise outcome predictions for immunotherapy in esophageal squamous cell cancer. Journal of translational medicine 22 (1) (2024)
Xiaochu Man, Jie Huang, Shujuan Sun, Dongdong Zhou, Baoxuan Zhang, Shu Fang, Fangchao Zheng, Chao Li, Xinzhao Wang, Wei Huang, Linlin Wang, Qingqing He, Hui Fu, Yan Zhang, Changrui Liu, Lin Dong, Xianguang Zhao, Liang Xu, Xiao Sun, Bingjie Fan, Lihua Song, Zhengbo Zhou, Jinming Yu, Huihui Li
Efficacy and safety of pyrotinib combined with albumin-bound paclitaxel as first-line treatment for HER2-positive metastatic breast cancer in patients previously treated with adjuvant and/or neoadjuvant trastuzumab therapy: The stage 1 results of a single-arm, phase 2 prospective clinical trial. Clinical and translational medicine 14 (5) (2024)
Yiyue Xu, Haoqian Li, Xiaoqing Wang, Butuo Li, Aiqin Gao, Qian Zhao, Linlin Yang, Wenru Qin, Linlin Wang
Development and Validation of Nomograms for Predicting Pneumonia in Patients with COVID-19 and Lung Cancer. Journal of inflammation research 17 (2024)
Xiaochu Man, Jie Huang, Shujuan Sun, Dongdong Zhou, Baoxuan Zhang, Shu Fang, Fangchao Zheng, Chao Li, Xinzhao Wang, Wei Huang, Linlin Wang, Qingqing He, Hui Fu, Yan Zhang, Changrui Liu, Lin Dong, Xianguang Zhao, Liang Xu, Xiao Sun, Bingjie Fan, Lihua Song, Zhengbo Zhou, Jinming Yu, Huihui Li
Efficacy and safety of pyrotinib combined with albumin-bound paclitaxel as first-line treatment for HER2-positive metastatic breast cancer in patients previously treated with adjuvant and/or neoadjuvant trastuzumab therapy: The stage 1 results of a single-arm, phase 2 prospective clinical trial. Clinical and translational medicine 14 (5) (2024)
Xiaochu Man, Jie Huang, Shujuan Sun, Dongdong Zhou, Baoxuan Zhang, Shu Fang, Fangchao Zheng, Chao Li, Xinzhao Wang, Wei Huang, Linlin Wang, Qingqing He, Hui Fu, Yan Zhang, Changrui Liu, Lin Dong, Xianguang Zhao, Liang Xu, Xiao Sun, Bingjie Fan, Lihua Song, Zhengbo Zhou, Jinming Yu, Huihui Li
Efficacy and safety of pyrotinib combined with albumin-bound paclitaxel as first-line treatment for HER2-positive metastatic breast cancer in patients previously treated with adjuvant and/or neoadjuvant trastuzumab therapy: The stage 1 results of a single-arm, phase 2 prospective clinical trial. Clinical and translational medicine 14 (5) (2024)
Butuo Li, Wenru Qin, Linlin Yang, Haoqian Li, Chao Jiang, Yueyuan Yao, Shuping Cheng, Bing Zou, Bingjie Fan, Taotao Dong, Linlin Wang
From pixels to patient care: deep learning-enabled pathomics signature offers precise outcome predictions for immunotherapy in esophageal squamous cell cancer. Journal of translational medicine 22 (1) (2024)
Yueyuan Yao, Butuo Li, Yiyue Xu, Linlin Yang, Bing Zou, Linlin Wang
East Asian patients who received immunotherapy-based therapy associated with improved survival benefit in advanced non-small cell lung cancer: An updated meta-analysis. Cancer medicine 13 (4) (2024)
Butuo Li, Wenru Qin, Linlin Yang, Haoqian Li, Chao Jiang, Yueyuan Yao, Shuping Cheng, Bing Zou, Bingjie Fan, Taotao Dong, Linlin Wang
From pixels to patient care: deep learning-enabled pathomics signature offers precise outcome predictions for immunotherapy in esophageal squamous cell cancer. Journal of translational medicine 22 (1) (2024)
Wenting Qie, Qian Zhao, Linlin Yang, Bing Zou, Yanan Duan, YueYuan Yao, Linlin Wang
Incidence of pneumonitis following the use of different anaplastic lymphoma kinase tyrosine kinase inhibitor regimens: An updated systematic review and meta-analysis. Cancer medicine (2023)
Linlin Yang, Qian Zhao, Jinming Yu, Linlin Wang
The addition of anlotinib reduces the incidence of radiation and immunotherapy-induced pneumonia. Journal of translational medicine 21 (1) (2023)
Linlin Yang, Butuo Li, Yiyue Xu, Bing Zou, Bingjie Fan, Chunni Wang, Linlin Wang
Pneumonitis with combined immune checkpoint inhibitors and chemoradiotherapy in locally advanced non-small-cell lung cancer: a systematic review and meta-analysis. Future oncology (London, England) (2023)
Yanan Duan, Wenru Qin, Linlin Yang, Bing Zou, Wenting Qie, Ruiting Song, Lu Xue, Linlin Wang
Safety and Efficacy of Concurrent or Sequential Radiotherapy Plus (PD-1) Inhibitors in Oligometastatic Esophageal Cancer. Cancer management and research 15 (2023)
Fengchun Mu, Bingjie Fan, Haoqian Li, Wenru Qin, Chunni Wang, Bing Zou, Linlin Wang
Impact of nab-paclitaxel plus PD-1/PD-L1 inhibitor on chemorefractory relapsed small-cell lung cancer. Future oncology (London, England) (2023)
Yanan Duan, Wenru Qin, Linlin Yang, Bing Zou, Wenting Qie, Ruiting Song, Lu Xue, Linlin Wang
Safety and Efficacy of Concurrent or Sequential Radiotherapy Plus (PD-1) Inhibitors in Oligometastatic Esophageal Cancer. Cancer management and research 15 (2023)
Fengchun Mu, Bingjie Fan, Butuo Li, Wenru Qin, Haoqian Li, Chunni Wang, Bing Zou, Shijiang Wang, Linlin Wang
Comparison of the Incidence Rate of Radiation Pneumonitis Observed in Patients with Advanced Lung Adenocarcinoma Treated with Simultaneous Thoracic Radiotherapy and 1G/2G/3G EGFR-TKIs. Cancer management and research 15 (2023)
Wenru Qin, Bing Zou, Xinyu Fan, Bingjie Fan, Shijiang Wang, Linlin Wang
Transformation from Small Cell to Squamous Cell Carcinoma in a Thymic Carcinoma Patient with a Durable Response to Anlotinib: A Case Report. Cancer management and research 14 (2022)
Linlin Yang, Xinyu Fan, Wenru Qin, Yiyue Xu, Bing Zou, Bingjie Fan, Shijiang Wang, Taotao Dong, Linlin Wang
A novel deep learning prognostic system improves survival predictions for stage III non-small cell lung cancer. Cancer medicine 11 (22) (2022)
Qian Zhao, Butuo Li, Yiyue Xu, Shijiang Wang, Bing Zou, Jinming Yu, Linlin Wang
Three models that predict the efficacy of immunotherapy in Chinese patients with advanced non-small cell lung cancer. Cancer medicine 10 (18) (2021)
Butuo Li, Chao Jiang, Ruiqing Wang, Bing Zou, Peng Xie, Wanlong Li, Xindong Sun, Jinming Yu, Linlin Wang
Prognostic Value of a Nomogram Based on the Dynamic Albumin-to-Alkaline Phosphatase Ratio for Patients with Extensive-Stage Small-Cell Lung Cancer. OncoTargets and therapy 13 (2020)
Yiyue Xu, Linlin Wang, Bo He, Wanlong Li, Qiang Wen, Shijiang Wang, Xindong Sun, Xue Meng, Jinming Yu
Development and validation of a risk prediction model for radiotherapy-related esophageal fistula in esophageal cancer. Radiation oncology (London, England) 14 (1) (2019)
Meiying Guo, Butuo Li, Yishan Yu, Shijiang Wang, Yiyue Xu, Xindong Sun, Linlin Wang, Jin-Ming Yu
Delineating the pattern of treatment for elderly locally advanced NSCLC and predicting outcomes by a validated model: A SEER based analysis. Cancer medicine 8 (5) (2019)